Sana Biotechnology, Inc.
SANA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $650,857 | $399,131 | $385,167 |
| - Cash | $103,357 | $71,271 | $96,131 | $127,566 |
| + Debt | $74,968 | $85,492 | $91,314 | $94,197 |
| Enterprise Value | – | $665,078 | $394,314 | $351,798 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$38,961 | -$47,507 | -$46,981 | -$45,173 |
| % Margin | – | – | – | – |
| Net Income | -$42,152 | -$93,800 | -$49,389 | -$49,069 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.16 | -0.39 | -0.21 | -0.21 |
| % Growth | 59% | -85.7% | 0% | – |
| Operating Cash Flow | -$29,429 | -$33,101 | -$48,657 | -$47,161 |
| Capital Expenditures | -$41 | $112 | -$136 | -$436 |
| Free Cash Flow | -$29,470 | -$32,989 | -$48,793 | -$47,597 |